investor harm

Class action lawsuit alleges Boston Scientific made false statements about U.S. electrophysiology segment sustainability, citing undisclosed competitive pressures and regulatory headwinds affecting procedure volumes.

Class action lawsuit alleges monday.com made false statements about revenue growth and sales cycles between September 2025 and February 2026, claiming investor harm.

Class action lawsuit filed against $EOS alleging securities fraud over undisclosed production delays, quality control issues, and inadequate guidance during Nov 2025-Feb 2026 period.

Class action lawsuit filed against $AMC alleging securities fraud over APE preferred equity units and undisclosed dividend exclusion loophole.

Class action lawsuit filed against Corcept Therapeutics alleges material misstatements about relacorilant drug trials and regulatory approval prospects, covering investors from October 2024 through December 2025.

Class action filed against $METC alleging executives made false statements about Brook Mine development progress. Investors who purchased securities July-October 2025 may be eligible.

Class action filed against NYSE-listed ChowChow Cloud alleging securities fraud involving market manipulation, social media misinformation, and undisclosed trading suspension risks for investors during September-December 2025.

Class action lawsuit filed against Nektar Therapeutics alleging materially false statements regarding REZOLVE-AA trial enrollment protocols, claiming compromised trial integrity.

Mereo BioPharma faces class action lawsuit alleging false statements about failed Phase 3 trials ORBIT and COSMIC. Investors from June 2023-December 2025 eligible; lead plaintiff deadline April 2026.

Securities fraud lawsuit filed against $DRVN alleging false financial statements, weak controls, and revenue overstatement from May 2023 through February 2026.

Class action lawsuit filed against $SNOW alleging securities fraud over concealed product changes and CEO departure rumors during June 2023-February 2024 period.

Class action lawsuit filed against $ORCL alleging executives misrepresented AI infrastructure spending impact. Claims massive CapEx won't yield equivalent near-term revenue growth.

Class action lawsuit filed against NuScale Power alleging securities fraud over misrepresented partner ENTRA1's nuclear experience, impacting commercialization strategy.

Law firm files class action against Beyond Meat for allegedly misleading investors about asset values and SEC filing delays from February-November 2025.

Class action lawsuit filed against $REGENXBIO alleging false statements on RGX-111 gene therapy. Covers investors from February 2022 to January 2026.

Class action lawsuit filed against $ENPH alleges company overstated inventory management capabilities and minimized 25D tax credit termination impact during April-October 2025 period.

Class action filed against Camping World Holdings alleging material false statements on inventory management and consumer demand forecasts during April 2025-February 2026 period; lead plaintiff deadline May 11, 2026.

Class action lawsuit filed against $PYPL alleging executives made false statements about revenue projections and 2027 targets. Lead plaintiff deadline set for April 20, 2026.

Class action lawsuit filed against $AQST alleging misleading statements about FDA approval timeline for Anaphylm and concealed human factors risks.

Class action lawsuit filed against monday.com alleging false revenue and growth statements from September 2025 to February 2026. Investors urged to participate in suit.